Pharmaceutical

Novo shells out $1.1bn to buy Cardior to expand cardiovascular pipeline

Novo Nordisk will pay up to $1.1bn in upfront and milestone-based payments, with the acquisition expected to close in Q2 2024.

Mar 26, 2024 - 00:00
Novo shells out $1.1bn to buy Cardior to expand cardiovascular pipeline
Novo Nordisk will pay up to $1.1bn in upfront and milestone-based payments, with the acquisition expected to close in Q2 2024.
Read the original article

Tags:

Previous Article

Pharmaceutical packaging companies and labelling machines

Next Article

Elahere secures full approval from FDA for types of ovarian cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: EU releases proposed pharma overhaul, cutting period of market exclusivity

STAT+: EU releases proposed pharma overhaul, cutting pe...

Apr 27, 2023

Opinion: Do dementia villages actually work? We just don’t know

Opinion: Do dementia villages actually work? We just do...

Oct 24, 2023

STAT+: Pharmalittle: We’re reading about LillyDirect, India’s drug standards, and more

STAT+: Pharmalittle: We’re reading about LillyDirect, I...

Jan 8, 2024